Wells Fargo Maintains Equal-Weight on Amphastar Pharma, Raises Price Target to $20

Wells Fargo analyst Benjamin Burnett maintains Amphastar Pharma (NASDAQ:AMPH) with a Equal-Weight and raises the price target from $19 to $20.